Boston Scientific Quarterly Balance Sheet
NYSE: BSXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Boston Scientific financial position
As of Jun 30, 2026, Boston Scientific reported total assets of $45.22 billion, up 8.8% from a year earlier against total liabilities of $20.04 billion. Shareholders' equity stood at $24.93 billion, or 55.1% of assets. The company held $539.0 million in cash and equivalents against $12.62 billion of debt, a net debt position of $12.09 billion.
The current ratio (current assets divided by current liabilities) was 1.24, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.51.
Summary generated from market data by MetaCap's automated system. Methodology
Boston Scientific balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 539.00M | 1.45B | 1.97B | 1.27B | 534.00M | 725.00M | 414.00M | 2.50B | 2.91B | 2.33B | 865.00M | 952.00M |
| Receivables | 3.05B | 3.03B | 2.93B | 2.83B | 2.81B | 2.69B | 2.56B | 2.50B | 2.40B | 2.30B | 2.23B | 2.10B |
| Inventory | 3.23B | 3.12B | 2.94B | 2.92B | 2.86B | 2.87B | 2.81B | 2.75B | 2.61B | 2.56B | 2.48B | 2.40B |
| Total Current Assets | 7.97B | 8.68B | 8.79B | 8.04B | 7.12B | 7.33B | 6.92B | 8.76B | 8.99B | 8.19B | 6.51B | 6.50B |
| Property, Plant & Equipment | 4.13B | 4.06B | 4.04B | 3.79B | 3.46B | 3.39B | 3.29B | 3.07B | 2.95B | 2.90B | 2.86B | 2.63B |
| Goodwill | 18.64B | 18.54B | 18.28B | 18.21B | 18.08B | 17.34B | 17.09B | 15.03B | 14.40B | 14.36B | 14.39B | 13.61B |
| Intangible Assets | 6.92B | 7.06B | 7.02B | 7.16B | 7.26B | 6.57B | 6.68B | 5.75B | 5.42B | 5.84B | 6.00B | 5.85B |
| Total Assets | 45.22B | 44.35B | 43.67B | 42.71B | 41.56B | 40.14B | 39.40B | 38.08B | 37.11B | 36.67B | 35.14B | 34.04B |
| Accounts Payable | 1.23B | 1.14B | 1.14B | 1.00B | 962.00M | 1.00B | 960.00M | 907.00M | 906.00M | 921.00M | 942.00M | 929.00M |
| Short-Term Debt | 1.71B | 41.00M | 299.00M | 483.00M | 480.00M | 777.00M | 1.78B | 1.65B | 1.58B | 1.08B | 531.00M | 513.00M |
| Total Current Liabilities | 6.43B | 4.57B | 5.44B | 5.33B | 5.19B | 5.06B | 6.40B | 5.91B | 5.58B | 4.92B | 4.93B | 4.58B |
| Long-Term Debt | 10.91B | 10.99B | 11.14B | 11.12B | 11.11B | 10.53B | 8.97B | 9.23B | 8.99B | 9.53B | 8.57B | 8.39B |
| Total Liabilities | 20.04B | 18.25B | 19.20B | 19.08B | 18.91B | 17.69B | 17.39B | 17.12B | 16.50B | 16.50B | 15.61B | 14.91B |
| Shareholders' Equity | 24.93B | 25.86B | 24.23B | 23.39B | 22.42B | 22.21B | 21.77B | 20.71B | 20.37B | 19.93B | 19.28B | 18.89B |
| Retained Earnings | 7.82B | 6.91B | 5.57B | 4.90B | 4.14B | 3.35B | 2.67B | 2.11B | 1.64B | 1.31B | 819.00M | 315.00M |
| Total Debt | 12.62B | 11.03B | 11.44B | 11.60B | 11.59B | 11.31B | 10.75B | 10.88B | 10.57B | 10.62B | 9.10B | 8.90B |
| Net Cash (Debt) | -12.09B | -9.58B | -9.47B | -10.32B | -11.05B | -10.58B | -10.33B | -8.38B | -7.66B | -8.29B | -8.24B | -7.95B |
This table shows 12 quarterly periods of Boston Scientific's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow BSX's reporting calendar. What is a balance sheet?